Coliseum Capital Further Trims Stake In Accuride Corporation (ACW)

Christopher Shackelton and Adam Gray have decided to further decrease their holding of Accuride Corporation (NYSE:ACW). Their fund, Coliseum Capital, has sold 115,160 shares in three transactions at prices between $5.17 and $5.2 per unit, as reported in a recent Form 4 filing with the Securities and Exchange Commission. Following this move, Coliseum Capital is left holding 7.59 million shares of Accuride Corporation (NYSE:ACW).

Accuride Logo

Peter Schliemann also thinks it is time to reduce exposure to Accuride Corporation (NYSE:ACW) and has decreased his fund’s stake by 5% during the first quarter of 2014. As a result, Rutabaga Capital Management has reported ownership of 2.39 million shares in its latest 13F filing. James Dinan is also keeping an eye on this stock with his fund, York Capital Management, reportedly holding 750,000 shares and having made no changes to the position during the first quarter. Chuck Royce is still optimistic about the prospects of Accuride Corporation (NYSE:ACW) and has boosted his fund’s stake by 32% during Q1 to 1.8 million shares.

Disclosure: none.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!